The Delaware Supreme Court rejected the legitimacy of expert testimony linking the heartburn drug Zantac to cancer, in a ...

Delaware's highest court ruled on Thursday that nearly 75,000 patients suing four large drugmakers cannot introduce reports ...

Delaware's top court reversed a ruling that allowed expert testimony in Zantac cancer lawsuits, citing improper legal ...

In the latest twist in the ocean of Zantac-related litigation playing out across state courts, drugmakers have notched a key ...

Zantac and its generic varieties are coming off store shelves after the Food and Drug Administration revealed it found a chemical that could be linked to cancer. Monday, pharmacy chains CVS and ...

After settlements with Zantac cancer victims in California, litigants prepare for next phase in the litigation involving over 70,000 cases The FDA pulled Zantac because it contained a potent ...

June 30 (Reuters) - The first U.S. trial over claims that discontinued heartburn drug Zantac causes cancer is now expected to take place in California state court on Nov. 13, a lawyer for ...

If you or a loved one has been diagnosed with cancer after using Zantac, Morgan & Morgan may be able to help. To see if you may be eligible to file a claim, take this online quiz.

Sandoz, a division of Novartis, has halted the worldwide distribution of its generic version of Zantac, a popular heartburn medication. In a statement to Fox 11, Dana Kahn Cooper, a spokesperson ...

Her suit alleges that the drug’s active ingredient, called ranitidine, turns into a cancer-causing substance called NDMA as it ages. GSK developed Zantac and later sold the over-the-counter ...

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK , opens new tab and other companies, causes cancer is set to begin this week in Chicago.

After settlements with Zantac cancer victims in California, litigants prepare for next phase in the litigation involving over 70,000 cases The FDA pulled Zantac because it contained a potent ...